Skip to main
CTOR
CTOR logo

Citius Oncology Inc (CTOR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy CTOR Stock

About Citius Oncology Inc (CTOR)

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.
Market cap$129.31M
Yesterday's volume10.51K
Revenue (TTM)
Avg. daily volume1.48M
EBITDA (TTM)
Open$1.56
Price / earnings ratio-8.67x
Yesterday's range$1.47 - $1.7
Debt / equity10.66x
52 week range$0.55 - $49
5 year debt / equity2.06x
Beta (LTM)-4.54x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.36x
Ex-dividend date
Next earningsAug 11, 2025
Dividend payable date

CTOR Stock Rating

What analysts recommend for CTOR stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 22, 2025, the market cap for CTOR stock is $129.32M

The current P/E ratio for CTOR stock is -8.67

The 52-week high for CTOR stock is $49. The current CTOR stock price $undefined is 100.00% below its 52-week high

The 52-week low for CTOR stock is $0.55. The current CTOR stock price $undefined has increased 100.00% from its 52-week low

No, the CTOR stock does not pay dividends to its shareholders

The target price for CTOR stock is $3 based on the average of what a group of analyst think CTOR stock could be worth at a future date. This is not a prediction by Public.com

How to buy CTOR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CTOR stock

    Navigate to the Explore page. Then, type CTOR into the search bar. When you see CTOR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CTOR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Citius Oncology Inc Stock Earnings

The value each CTOR share was expected to gain vs. the value that each CTOR share actually gained.

CTOR (CTOR) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, CTOR's earnings per share (EPS) was $0. CTOR is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of $0.

Buy CTOR Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.